STRUCTURAL ANOMALY OF LEFT LATERAL TEMPORAL LOBE IN EPILEPSY DUE TO MUTATED LGI1

Autosomal dominant lateral temporal epilepsy (ADTLE) is a syndrome characterized by ictal auditory phenomena suggesting a lateral temporal lobe seizure onset and is associated with mutations in the leucine-rich, glioma inactivated 1 (LGI1) gene.1,2 The structure of the LGI1 protein includes, in the N-terminal portion, three leucine-rich repeats (LRR). The function of LGI1 and the mechanisms underlying epilepsy in patients with LGI1 mutations are not established. However, LGI1 is involved in the control of survival of neuroblastoma cell lines.3 This feature and the structural homology between LGI1 and other LRR proteins essential for the development of the CNS3 make it conceivable that LGI1 mutations could imply some structural abnormalities of the lateral temporal lobe as the substratum underlying partial epilepsy in ADTLE. Neuropathologic data are lacking and conventional MRI studies failed to show consistent findings in ADTLE.1,2 Voxel-based analyses enable detection of subtle regional differences in MR images.4,5 ### Methods. We performed voxel-based analyses of T1-weighted, diffusion-tensor, and magnetization transfer (MT) images of the brain in 8 patients (3 women and 5 men, mean age 49 ± 13 years) with ADTLE and LGI1 mutations and 24 healthy control subjects (14 women and 10 men, mean …

[1]  R. Della Nave,et al.  Whole-Brain Histogram and Voxel-Based Analyses of Diffusion Tensor Imaging in Patients with Leukoaraiosis: Correlation with Motor and Cognitive Impairment , 2007, American Journal of Neuroradiology.

[2]  E. Mignot,et al.  Narcolepsy with cataplexy , 2007, The Lancet.

[3]  Josep Dalmau,et al.  Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma , 2007, Annals of neurology.

[4]  R. Michelucci,et al.  Increased expression of LGI1 gene triggers growth inhibition and apoptosis of neuroblastoma cells , 2006, Journal of cellular physiology.

[5]  A. Alavi,et al.  Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. , 2005, Brain : a journal of neurology.

[6]  S. Nishino,et al.  Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. , 2005, Sleep medicine reviews.

[7]  O. Steinlein,et al.  Speech‐induced Aphasic Seizures in Epilepsy Caused by LGI1 Mutation , 2005, Epilepsia.

[8]  H. Shibasaki,et al.  Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis , 2004, Journal of Neurology.

[9]  T. Scammell,et al.  Narcolepsy caused by acute disseminated encephalomyelitis. , 2004, Archives of neurology.

[10]  J. Touchon,et al.  CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions , 2003, Journal of neurology, neurosurgery, and psychiatry.

[11]  E. Mignot,et al.  The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. , 2002, Archives of neurology.

[12]  J. Oger,et al.  Potassium channel antibodies in two patients with reversible limbic encephalitis , 2001, Annals of neurology.

[13]  D K Burns,et al.  Isolated neck extensor myopathy , 1996, Neurology.

[14]  N. Risch,et al.  Localization of a gene for partial epilepsy to chromosome 10q , 1995, Nature Genetics.

[15]  D. Greenblatt,et al.  The International Classification of Sleep Disorders , 1992 .

[16]  P. S. Sillevis Smitt,et al.  Managing paraneoplastic neurological disorders. , 2006, The oncologist.